Literature DB >> 16267208

Activation and potentiation of interferon-gamma signaling by 3,3'-diindolylmethane in MCF-7 breast cancer cells.

Jacques E Riby1, Ling Xue, Urmi Chatterji, Erik L Bjeldanes, Gary L Firestone, Leonard F Bjeldanes.   

Abstract

3,3'-Diindolylmethane (DIM), a natural autolytic product in plants of the Brassica genus, including broccoli, cauliflower, and Brussels sprouts, exhibits promising cancer protective activities, especially against mammary neoplasia in animal models. We observed previously that DIM induced a G(1) cell-cycle arrest and strong induction of cell-cycle inhibitor p21 expression and promoter activity in both estrogen-responsive and -independent breast cancer cell lines. We showed recently that DIM up-regulates the expression of interferon gamma (IFNgamma) in human MCF-7 breast cancer cells. This novel effect may contribute to the anticancer effects of DIM because IFNgamma plays an important role in preventing the development of primary and transplanted tumors. In this study, we observed that DIM activated the IFNgamma signaling pathway in human breast cancer cells. DIM activated the expression of the IFNgamma receptor (IFNGR1) and IFNgamma-responsive genes p56- and p69-oligoadenylate synthase (OAS). In cotreatments with IFNgamma, DIM produced an additive activation of endogenous p69-OAS and of an OAS-Luc reporter and a synergistic activation of a GAS-Luc reporter. DIM synergistically augmented the IFNgamma induced phosphorylation of signal transducer and activator of transcription factor 1, further evidence of DIM activation of the IFNgamma pathway. DIM and IFNgamma produced an additive inhibition of cell proliferation and a synergistic increase in levels of major histocompatibility complex class-1 (MHC-1) expression, accompanied by increased levels of mRNAs of MHC-1-associated proteins and transporters. These results reveal novel immune activating and potentiating activities of DIM in human tumor cells that may contribute to the established effectiveness of this dietary indole against various tumors types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267208     DOI: 10.1124/mol.105.017053

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

1.  3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.

Authors:  Massod Rahimi; Kai-Ling Huang; Careen K Tang
Journal:  Cancer Lett       Date:  2010-03-17       Impact factor: 8.679

2.  Microwave-assisted, one-pot reaction of 7-azaindoles and aldehydes: a facile route to novel di-7-azaindolylmethanes.

Authors:  Md Imam Uddin; Jason R Buck; Michael L Schulte; Dewei Tang; Samir A Saleh; Yiu-Yin Cheung; Joel Harp; H Charles Manning
Journal:  Tetrahedron Lett       Date:  2014-01-01       Impact factor: 2.415

3.  3,3'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression.

Authors:  Zhengping Zhang; Zhongfei Gao; Wei Hu; Shan Yin; Chunming Wang; Yuhui Zang; Jiangning Chen; Junfeng Zhang; Lei Dong
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

4.  Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology.

Authors:  Daniel W Sepkovic; Johann Stein; Antoine D Carlisle; H Barbara Ksieski; Karen Auborn; Laura Raucci; Themba Nyirenda; H Leon Bradlow
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-07

Review 5.  Minireview: modulation of hormone receptor signaling by dietary anticancer indoles.

Authors:  Gary L Firestone; Shyam N Sundar
Journal:  Mol Endocrinol       Date:  2009-10-16

6.  Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model.

Authors:  Daniel W Sepkovic; Johann Stein; Antoine D Carlisle; H Barbara Ksieski; Karen Auborn; H Leon Bradlow
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

Review 7.  Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.

Authors:  Cynthia A Thomson; Emily Ho; Meghan B Strom
Journal:  Nutr Rev       Date:  2016-05-31       Impact factor: 7.110

8.  3,3'-Diindolylmethane stimulates murine immune function in vitro and in vivo.

Authors:  Ling Xue; James J Pestka; Maoxiang Li; Gary L Firestone; Leonard F Bjeldanes
Journal:  J Nutr Biochem       Date:  2007-08-17       Impact factor: 6.048

Review 9.  Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.

Authors:  Philip B Busbee; Michael Rouse; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Nutr Rev       Date:  2013-04-01       Impact factor: 7.110

10.  BreastDefend enhances effect of tamoxifen in estrogen receptor-positive human breast cancer in vitro and in vivo.

Authors:  Shujie Cheng; Victor Castillo; Matt Welty; Mark Alvarado; Isaac Eliaz; Constance J Temm; George E Sandusky; Daniel Sliva
Journal:  BMC Complement Altern Med       Date:  2017-02-16       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.